LUGPA Medlive Virtual Event Series

In collaboration with PlatformQ Health, LUGPA offers members the opportunity to register and participate in a unique educational platform on Medlive. Attendees can take advantage of live streaming panel discussions and debates, along with interactive audience participation, including real-time question and answer sessions with top faculty.

LUGPA Virtual Crossfire and CME Event Series

LUGPA’s Virtual Crossfire Event Series with Medlive is like a live medical conference brought directly to your computer. Participants can choose to submit questions for the expert panel ahead of time or during the live broadcast, allowing presenters to respond in real time, combining benefits of in-person interactive education with the convenience of digital access.

_____________________________________________________________________________

UPCOMING EVENTS:

Taking a Closer Look at High-Risk, Biochemically Recurrent Prostate Cancer
CME Available on-demand: August 5, 2024

Learning Objectives

Identify patients with locally advanced prostate cancer who are at a high risk of progression
Evaluate novel treatment combinations of androgen deprivation therapy with androgen receptor inhibitors for patients with high-risk, biochemically recurrent prostate cancer
Develop solutions to address disparities in care for men of minority ethnic or socioeconomic backgrounds diagnosed with prostate cancer

Program Faculty:
Neal Shore, MD, FACS & Alicia K. Morgans, MD, MPH

More Events Coming Soon.

ON DEMAND SESSIONS:

Programs expire six months after their live date.

Real-World Data Guides LG-UTUC Treatment Strategies - originally launched 06/25/2024

Learning Objectives:

Review guideline-based management of low-grade upper tract urothelial carcinoma
Discuss the application of real-world data that can further refine current practice

Speakers: Jason M. Hafron, MD; David Morris, MD, FACS; Rian Dickstein, MD, FACS

Refining Treatment Strategies for mHSPC - originally launched May 29, 2024
Neal Shore, MD, FACS moderates a conversation between Gregory C. McMahon, DO and Benjamin Lowentritt, MD, FACS. During this session, our expert panel will discuss the rationale for triplet versus doublet therapies in mHSPC, and they identify how racial and ethnic minorities face disparities in treatment and care. Plus: don't miss out on the audience Q&A!

Program expiration: Nov. 29, 2024

Refining PSMA Testing in Prostate Cancer: Next-Generation Imaging Strategies - launched May 16, 2024 on-demand

Faculty:

Dr. Jason Hafron, Michigan Institute of Urology
Dr. David Schuster, Emory University School of Medicine

CME credit available.

Program expiration: Nov. 16, 2024

Practice Matters: Introducing Kidney-Sparing Approaches to UTUC Care

Live Date: 02/26/2024
Program expiration: 08/26/2024

EXPIRED PROGRAMS

Maintaining Health and Wellbeing in Patients with mHSPC
Live date: January 16, 2024
Program expiration: June 16, 2024

Practical Considerations in Low-grade UTUC Care
Live date: November 28, 2023
Program expiration: May 28, 2024

Optimizing Decision-Making for Patients with mHSPC: Case-Based Review of Doublets and Triplets
Live Date: 10/31/2023
Program Expiration: 3/2/24

Adopting a Kidney-Sparing Approach to UTUC Treatment (NON-CME)
Originally presented 8/31/2023
Program Expiration: 3/2/2024

Moving Beyond ADT Alone: The Rationale for Early Intensification in mHSPC
Originally presented July 12, 2023
Program Expiration: 1/19/2024

Programs expire six months after their live date.